FLT3L-DEPENDENT CD103+DC ARE CRUCIAL FOR THE INITIATION AND MAINTENANCE OF COLLAGEN-INDUCED ARTHRITIS by Ramos, M, Aarrass, S, Jacobsen, S, Tak, P, Lebre, M

FLT3L-DEPENDENT CD103+DC ARE CRUCIAL FOR THE INITIATION AND MAINTENANCE OF COLAGEN-INDUCED ARTHRITIS by Ramos, M, Aarrass, S, Jacobsen, S, Tak, P, Lebre, M

MICE LACKING FLT3L ARE PROTECTED FROM COLLAGEN-INDUCED ARTHRITIS: IMPAIRED T CELL FUNCTION? by Ramos, M, Karpus, O, Aarrass, S, Jacobsen, SE, Tak, P, Lebre, M

IL-17A producing mast cells as therapeutic target in spondyloarthritis by Canete J, Tak P P, Noordenbos T, Gofita I, Yeremenko N, Baeten D

TNF and IL-6 differentially regulate the production of DKK-1, a master regulator of bone remodelling, by fibroblast-like synoviocytes by Baeten D, Tak P P, Schett G, Zwerina J, Bisoendial R, Yeremenko N

Absence of Fms-like tyrosine kinase 3 ligand (Flt3L) signalling protects against collagen-induced arthritis. by Ramos, M, Karpus, O, Broekstra, P, Aarrass, S, Jacobsen, SE, Tak, P, Lebre, M

MICE LACKING FLT3L ARE PROTECTED FROM COLLAGEN-INDUCED ARTHRITIS: REGULATING THE REGULATORS by Ramos, M, Karpus, O, Broekstra, P, Aarrass, S, Jacobsen, SE, Tak, P, Lebre, M

Identification of distinct polarized macrophage subsets in inflammatory arthritis by Baeten D, Tak P P, Radstake TRDJ, Wenink M H, Hamann J, Krausz S, Ambarus C

Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis. by Tak, P, Taylor, P, Breedveld, F, Smeets, T, Daha, MR, Kluin, P, Meinders, A, Maini, R

Efficacy and safety of monotherapy with sirukumab, an anti-IL-6 cytokine monoclonal antibody, compared with adalimumab monotherapy in biologic-naive patients with active rheumatoid... by Taylor, P, Schiff, M, Wang, Q, Jiang, Y, Kurrasch, R, Daga, S, Rao, R, Hsu, B, Tak, P

Efficacy and safety of monotherapy with sirukumab compared to adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-... by Taylor, P, Schiff, M, Wang, Q, Jiang, Y, Zhuang, Y, Kurrasch, R, Daga, S, Rao, R, Tak, P, Hsu, B

Stromal cell markers are differentially expressed in the synovial tissue of patients with early arthritis by Choi, I, Karpus, O, Turner, J, Hardie, D, Marshall, J, de Hair, M, Maijer, K, Tak, P, Raza, K, Hamann, J, Buckley, C, Gerlag, D, Filer, A

Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema. by Lassere, M, Johnson, K, Boers, M, Tugwell, P, Brooks, P, Simon, L, Strand, V, Conaghan, P, Ostergaard, M, Maksymowych, W, Landewe, R, Bresnihan, B, Tak, P, Wakefield, R, Mease, P, Bingham, C, Hughes, M, Altman, D, Buyse, M, Galbraith, S, Wells, G

Animal models for arthritis: innovative tools for prevention and treatment. by Kollias, G, Papadaki, P, Apparailly, F, Vervoordeldonk, M, Holmdahl, R, Baumans, V, Desaintes, C, Di Santo, J, Distler, J, Garside, P, Hegen, M, Huizinga, T, Jüngel, A, Klareskog, L, McInnes, I, Ragoussis, I, Schett, G, Hart, B, Tak, P, Toes, R, van den Berg, W, Wurst, W, Gay, S